The triple receptor mechanism targeting GIP, GLP-1, and glucagon pathways simultaneously creates a synergistic effect that single and dual agonist peptides cannot match
Originally developed for type II diabetes, it is now widely used to help patients lose weight when combined with diet and exercise
That dual mechanism produces powerful metabolic effects, but it also amplifies gastrointestinal side effects in some individuals
One placebo-controlled trial revealed that weight loss injections treatments resulted in sustained body weight reductions for overweight and obese patients.1 The patients also made positive changes to their lifestyles during the study period
Step 2 A licensed clinician reviews your history, contraindications, and goals before any prescription is written
Although many people need to stay on semaglutide or tirzepatide long-term, some folks can come off these medications